Database: EUROCARE (European Union): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 23: Line 23:


'''Contact information:''' [https://www.iss.it/en/eurocare-chi-siamo Click here to access.]
'''Contact information:''' [https://www.iss.it/en/eurocare-chi-siamo Click here to access.]
{{Mouth}}
{{Throat}}
{{Oropharynx}}
{{Nasopharynx}}
{{Hypopharynx}}
{{Larynx}}
{{Salivary glands}}
{{Lips}}
{{Tonsils}}
{{base of tongue}}
{{Voice box}}
{{Esophagus}}
{{Stomach}}
{{Small intestine}}
{{Large intestine}}
{{Colon}}
{{Rectum}}
{{Anus}}
{{Liver}}
{{Gallbladder}}
{{Bile ducts}}
{{Pancreas}}
{{Lung}}
{{Trachea}}
{{Bronchi}}
{{Pleura}}
{{Mediastinum}}
{{Bone}}
{{Cartilage}}
{{Osteosarcoma}}
{{Ewings sarcoma}}
{{Skin}}
{{Melanoma}}
{{Scalp}}
{{Lips}}
{{Hands}}
{{Feet}}
{{Muscle}}
{{Fat}}
{{Tendon}}
{{Ligament}}
{{Blood vessels}}
{{Connective tissue}}
{{Sarcoma}}
{{Angiosarcoma}}
{{Liposarcoma}}
{{Lobular}}
{{Breast}}
{{Nipple}}
{{Areola}}
{{Ductal}}
{{Vulva}}
{{Vagina}}
{{Cervix}}
{{Uterus}}
{{Ovary}}
{{Fallopian tubes}}
{{Endometrium}}
{{Prostate}}
{{Testicles}}
{{Penis}}
{{Kidney}}
{{Ureter}}
{{Bladder}}
{{Urethra}}
{{Eye}}
{{Brain}}
{{Spinal cord}}
{{Thyroid gland}}
{{Parathyroid}}
{{Adrenal glands}}
{{Pituitary gland}}
{{Pancreas}}
{{Thymus gland}}
{{Peritoneum}}
{{Pericardium}}
{{Retroperitoneum}}
{{Mesothelium}}
{{Blood}}
{{Bone marrow}}
{{Lymph nodes}}
{{Spleen}}
{{Leukemia}}

Revision as of 20:01, 9 September 2024

Go back to European Union page

Type of Database: registry

Primary purpose: To monitor cancer survival, measure cancer prevalence, and study patterns of care for cancer patients across Europe. Click here to learn more.

Sponsor, manager or home institution: the Istituto Nazionale dei Tumori (INT Milan) and the Istituto Superiore di Sanità (Rome). Patient-level data is owned by each individual cancer registry. Click here to learn more.

Type of information: longitudinal. Cancer Site, year, Population, age Class, ICSS - International cancer survival Standards, Time from Diagnosis, sex, and Output Indicators including: Alive at Start, Observed Survival, Cumulative (OSC), Relative Survival, Cumulative (RSC), Relative SE's, Cumulative (RSEC), Dead, Expected Survival, Interval (ESI), Observed SE's, Interval (OSEI), RSC: Lower bound (95% CI), Lost to Follow Up, Expected Survival, Cumulative (ESC), Observed SE's, Cumulative (OSEC), RSC: Upper bound (95% CI), Observed Survival, Interval (OSI), Relative Survival, Interval (RSI), Relative SE's, Interval (RSEI). Click here to learn more.

Source of Information: 99 cancer registries from 29 countries participating in the study provided their patient-level data as of the 5th Edition of EUROCARE. Click here to learn more.

Data level: national level.

Number of Records: 9,000,000. Click here to learn more.

Date range: 2000 to 2007.

Cancer Areas of Interest: C00-C97: All cancer types. Click here to learn more.

Data access: publicly available. Click here to access. Databases from previous editions of the EUROCARE study are also available. Click here to access. Data can be downloaded in the formats XLS and TXT.

Contact information: Click here to access.